Literature DB >> 7621076

Severe colitis in mice with aberrant thymic selection.

G A Holländer1, S J Simpson, E Mizoguchi, A Nichogiannopoulou, J She, J C Gutierrez-Ramos, A K Bhan, S J Burakoff, B Wang, C Terhorst.   

Abstract

Tg epsilon 26 mice display an arrest very early in T cell development that has a profound effect on the architecture of thymic stromal cells. We have recently demonstrated that transplantation of wild-type bone marrow cells restores the thymic microenvironment of fetal but not adult Tg epsilon 26 mice. Here, we report that T cell-reconstituted adult Tg epsilon 26 mice develop a spontaneous wasting syndrome characterized by extensive inflammation of the colon, resembling human ulcerative colitis. Colitis in these animals was marked by substantial infiltration of the colon by activated thymus-derived CD4+ T cells. Importantly, bone marrow-transplanted Tg epsilon 26 mice previously engrafted with a fetal Tg epsilon 26 thymus did not develop colitis. These results suggest that T cells selected in an aberrant thymic microenvironment contain a population of cells able to induce severe colitis that can be prevented by T cells that have undergone normal thymic development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621076     DOI: 10.1016/1074-7613(95)90156-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  44 in total

1.  Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease.

Authors:  M M Kosiewicz; C C Nast; A Krishnan; J Rivera-Nieves; C A Moskaluk; S Matsumoto; K Kozaiwa; F Cominelli
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

Review 3.  Serologic testing in inflammatory bowel disease: its value in indeterminate colitis.

Authors:  K A Papadakis; S R Targan
Journal:  Curr Gastroenterol Rep       Date:  1999-12

Review 4.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

5.  Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease.

Authors:  L S Toy; X Y Yio; A Lin; S Honig; L Mayer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

6.  Aberrant T-cell ontogeny and defective thymocyte and colonic T-cell chemotactic migration in colitis-prone Galphai2-deficient mice.

Authors:  Kristina Elgbratt; Malin Bjursten; Roger Willén; Paul W Bland; Elisabeth Hultgren Hörnquist
Journal:  Immunology       Date:  2007-05-09       Impact factor: 7.397

7.  Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease.

Authors:  Patrick Chamouard; Fanny Monneaux; Zoe Richert; Anne-Claire Voegeli; Thomas Lavaux; Marie Pierre Gaub; René Baumann; Pierre Oudet; Sylviane Muller
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

Review 8.  Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

Authors:  K M Das
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

Review 9.  Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis.

Authors:  Kazuichi Okazaki; Hiroshi Nakase; Norihiko Watanabe; Yasuhiko Tabata; Yoshito Ikada; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

10.  Mouse adenovirus type 1 infection of natural killer cell-deficient mice.

Authors:  Amanda R Welton; Lisa E Gralinski; Katherine R Spindler
Journal:  Virology       Date:  2007-12-21       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.